Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05000502 · ClinicalTrials.gov registry record · NA

Exercise, Gut Microbiome, and Breast Cancer: Increasing Reach to Underserved Populations

A NA study, sponsored by University of Alabama at Birmingham.

Completed
Registry status
NA
Development phase
48
Enrollment target

NCT05000502 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 48 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05000502, a NA study, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
NA
Development phase
48 participants
Enrollment target

Study Summary

Understanding the impact exercise has on a cancer survivor's gut microbiome can improve the health and well-being of cancer survivors by enhancing treatments targeting the gut microbiome. Although scientific studies support a link between exercise and the gut microbiome, rigorous randomized trials needed to confirm this causal link are limited and usually involve supervised exercise. Hence, this proposal tests feasibility of a home-based, remote-only research protocol that is more accessible to cancer survivors unable to attend supervised exercise including but not limited to rural populations. This study will also determine if exercise effects on the gut microbiome differ by factors such as race.

Interventions

  • BEHAVIORAL Home-based exercise intervention

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2021-09-01
Est. Completion 2024-01-31
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT05000502

The ClinicalTrials.gov registry entry for NCT05000502 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Home-based exercise intervention is the first listed.

NCT05000502 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05000502 about?

NCT05000502 is a clinical study titled "Exercise, Gut Microbiome, and Breast Cancer: Increasing Reach to Underserved Populations". Understanding the impact exercise has on a cancer survivor's gut microbiome can improve the health and well-being of cancer survivors by enhancing treatments targeting the gut microbiome. Although scientific studies support a link between exercise and the gut microbiome, rigorous randomized trials n...

What is the current status of trial NCT05000502?

This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2021-09-01. Estimated completion is 2024-01-31.

What interventions are being tested in trial NCT05000502?

The interventions under investigation include: Home-based exercise intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT05000502?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.